ARCHIVES OF

THE BALKAN MEDICAL UNION

The official journal of the Balkan Medical Union, since 1935

Citation Abbreviation:

Arch Balk Med Union

The applicability of Methotrexate Intolerance Severity Score in juvenile idiopathic arthritis patients with MTHFR polymorphisms

0

Introduction. Many patients with juvenile idiopathic arthritis (JIA) experience gastrointestinal side effects after methotrexate (MTX) administration. Methotrexate Intolerance Severity Score (MISS) discriminates between patients with and without MTX intolerance, and helps to assess severity of adverse reactions, dose adjustment, mode of administration, or manage intolerance.
The objective of the study was to evaluate the applicability of MISS regarding methylenetetrahydrofolate reductase (MTHFR) polymorphisms in JIA.
Material and methods. The study included 68 JIA patients on MTX, MTHFR evaluated through CFX96 Touch Real-Time polymerase chain reaction (PCR) System, Bio-Rad. The assay is a qualitative method with 100% clinical specificity. MISS consists of four domains: abdominal pain, nausea, vomiting, and behavioural symptoms. It records anticipatory and associated symptoms after MTX administration. A score of ≥6 on MISS, including at least one anticipatory, associative, or behavioural symptom, described as MTX intolerance.
Results. The samples included combined and isolated 677TT and 677CT + 1298AC patients. An average score of 10.22 (95% CI: 8.73–11.71) found in the study group, defining gastrointestinal intolerance to MTX. A disproportionate score 2.84 (95% CI: 2.29–3.40) resulted in the control group, not corresponding the definition of MISS intolerance. The adverse effects came in response to previous symptoms often not clinically apparent and often inadequately managed. The predominant factors driving MTX intolerance are behavioural factors.
Conclusions. JIA patients may develop anticipatory, behavioural, and associated symptoms when they think about MTX. MISS helps in determining the on- set and evolution of these symptoms.
Keywords: juvenile idiopathic arthritis, MTHFR, MISS, intolerance, methotrexate.

Address for correspondence:
Vladimir IACOMI
Department of Pediatrics, “Nicolae Testemitanu” State University of Medicine and Pharmacy, Chisinau, Republic of Moldova
Address: 24/1 Lev Tolstoi Street, apartment 301, MD2001, Chisinau, Republic of Moldova
Email: vladimir.iacomi@usmf.md; Phone +373 680 809 95

Share.

Comments are closed.

Iacomi V, Cuterac A, Motelica I, Revenco N. The applicability of Methotrexate Intolerance Severity Score in juvenile idiopathic arthritis patients with MTHFR polymorphisms.  Arch Balk Med Union. 2026;61(1):77-85.

https://doi.org/10.31688/ABMU.2026.61.1.09

Exit mobile version